Chimerix Inc (CMRX)
0.9658
-0.05
(-5.31%)
USD |
NASDAQ |
May 10, 16:00
0.9658
0.00 (0.00%)
After-Hours: 19:14
Chimerix Total Return Price: 0.9658 for May 10, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.02 |
| May 08, 2024 | 0.9706 |
| May 07, 2024 | 0.99 |
| May 06, 2024 | 1.00 |
| May 03, 2024 | 0.9529 |
| May 02, 2024 | 0.9502 |
| May 01, 2024 | 0.95 |
| April 30, 2024 | 0.94 |
| April 29, 2024 | 0.9346 |
| April 26, 2024 | 0.8999 |
| April 25, 2024 | 0.891 |
| April 24, 2024 | 0.906 |
| April 23, 2024 | 0.9253 |
| April 22, 2024 | 0.9139 |
| April 19, 2024 | 0.8844 |
| April 18, 2024 | 0.9323 |
| April 17, 2024 | 0.904 |
| April 16, 2024 | 0.9201 |
| April 15, 2024 | 0.9146 |
| April 12, 2024 | 0.9607 |
| April 11, 2024 | 0.99 |
| April 10, 2024 | 0.999 |
| April 09, 2024 | 0.99 |
| April 08, 2024 | 1.00 |
| April 05, 2024 | 1.03 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.04 |
| April 03, 2024 | 1.04 |
| April 02, 2024 | 1.01 |
| April 01, 2024 | 1.05 |
| March 28, 2024 | 1.06 |
| March 27, 2024 | 1.01 |
| March 26, 2024 | 0.99 |
| March 25, 2024 | 0.9845 |
| March 22, 2024 | 0.9998 |
| March 21, 2024 | 0.956 |
| March 20, 2024 | 0.99 |
| March 19, 2024 | 0.96 |
| March 18, 2024 | 1.10 |
| March 15, 2024 | 1.15 |
| March 14, 2024 | 1.14 |
| March 13, 2024 | 1.17 |
| March 12, 2024 | 1.18 |
| March 11, 2024 | 1.24 |
| March 08, 2024 | 1.26 |
| March 07, 2024 | 1.26 |
| March 06, 2024 | 1.25 |
| March 05, 2024 | 1.21 |
| March 04, 2024 | 1.18 |
| March 01, 2024 | 1.17 |
| February 29, 2024 | 1.15 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.8844
Minimum
Apr 19 2024
11.25
Maximum
Feb 17 2021
3.364
Average
2.33
Median
Jan 06 2020
Total Return Price Benchmarks
| UFP Technologies Inc | 260.99 |
| Dentsply Sirona Inc | 27.89 |
| Arbutus Biopharma Corp | 2.885 |
| Pacira BioSciences Inc | 29.37 |
| Karyopharm Therapeutics Inc | 1.09 |